Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Repasky

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2008
Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linkerEzogelin Oflazoglu, Ivan J Stone, Kristine Gordon, et al.
International Reviews of Immunology|September 30, 2017
Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapyEzekiel Maloney, Tanya Khokhlova, Venu G Pillarisetty, et al.
Cancer Biology & Therapy|October 16, 2009
Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenograftsMukund Seshadri, Mihai Merzianu, Haikuo Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 5, 2018
An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancerXiang Ling, Wenjie Wu, Chuandong Fan, et al.
The Journal of Clinical Investigation|October 1, 2019
β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cellsHemn Mohammadpour, Cameron R MacDonald, Guanxi Qiao, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 10, 2010
Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivoHilal Arnouk, Evan R Zynda, Xiang-Yang Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2011
CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanomaJie Qian, Huanfa Yi, Chunqing Guo, et al.
Cancer Research|April 23, 2011
Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor modelsArindam Sen, Maegan L Capitano, Joseph A Spernyak, et al.
Vaccines|November 26, 2025
A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune RemodelingXueqian Cheng, Zheng Liu, Jinyang Cai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2015
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor modelBonnie L Hylander, Arindam Sen, Sarah H Beachy, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2008
Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linkerEzogelin Oflazoglu, Ivan J Stone, Kristine Gordon, et al.
International Reviews of Immunology|September 30, 2017
Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapyEzekiel Maloney, Tanya Khokhlova, Venu G Pillarisetty, et al.
Cancer Biology & Therapy|October 16, 2009
Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenograftsMukund Seshadri, Mihai Merzianu, Haikuo Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 5, 2018
An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancerXiang Ling, Wenjie Wu, Chuandong Fan, et al.
The Journal of Clinical Investigation|October 1, 2019
β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cellsHemn Mohammadpour, Cameron R MacDonald, Guanxi Qiao, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 10, 2010
Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivoHilal Arnouk, Evan R Zynda, Xiang-Yang Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2011
CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanomaJie Qian, Huanfa Yi, Chunqing Guo, et al.
Cancer Research|April 23, 2011
Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor modelsArindam Sen, Maegan L Capitano, Joseph A Spernyak, et al.
Vaccines|November 26, 2025
A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune RemodelingXueqian Cheng, Zheng Liu, Jinyang Cai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2015
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor modelBonnie L Hylander, Arindam Sen, Sarah H Beachy, et al.
Pageof 15